+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery

Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery

Analytical Chemistry 87(21): 10755-10761

Cerebrospinal fluid (CSF) is a body fluid of high clinical relevance and an important source of potential biomarkers for brain-associated damages, such as traumatic brain injury and stroke, and for brain diseases, such as Alzheimer's and Parkinson's. Herein, we have implemented, evaluated, and validated a scalable automated proteomic pipeline (ASAP(2)) for the sample preparation and proteomic analysis of CSF, enabling increased throughput and robustness for biomarker discovery. Human CSF samples were depleted from abundant proteins and subjected to automated reduction, alkylation, protein digestion, tandem mass tag (TMT) 6-plex labeling, pooling, and sample cleanup in a 96-well-plate format before reversed-phase liquid chromatography tandem mass spectrometry (RP-LC MS/MS). We showed the impact on the CSF proteome coverage of applying the depletion of abundant proteins, which is usually performed on blood plasma or serum samples. Using ASAP(2) to analyze 96 identical CSF samples, we determined the analytical figures of merit of our shotgun proteomic approach regarding proteome coverage consistency (i.e., 387 proteins), quantitative accuracy, and individual protein variability. We demonstrated that, as for human plasma samples, ASAP(2) is efficient in analyzing large numbers of human CSF samples and is a valuable tool for biomarker discovery. The data has been deposited to the ProteomeXchange with identifier PXD003024.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058653734

Download citation: RISBibTeXText

PMID: 26452177

DOI: 10.1021/acs.analchem.5b02748

Related references

Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery. Methods in Molecular Biology 1959: 89-112, 2019

Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. Journal of Proteomics 74(4): 371-388, 2011

Alzheimer's disease cerebrospinal fluid biomarker discovery: a proteomics approach. Current Opinion in Molecular Therapeutics 7(6): 557-564, 2005

Preparation of human cerebrospinal fluid for proteomics biomarker analysis. Methods in Molecular Biology 1002: 61-70, 2014

Automated image alignment for 2D gel electrophoresis in a high-throughput proteomics pipeline. Bioinformatics 24(7): 950-957, 2008

An automated pipeline for high-throughput label-free quantitative proteomics. Journal of Proteome Research 12(4): 1628-1644, 2014

Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis. Proteomics. Clinical Applications 7(1-2): 91-108, 2014

High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS. Journal of Lipid Research 58(7): 1482-1489, 2017

Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue. Journal of Mammary Gland Biology and Neoplasia 17(2): 155-164, 2013

Discovery proteomics and nonparametric modeling pipeline in the development of a candidate biomarker panel for dengue hemorrhagic fever. Clinical and Translational Science 5(1): 8-20, 2012

Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. Journal of Proteome Research 2014, 2014

A Highly Automated Shotgun Proteomic Workflow: Clinical Scale and Robustness for Biomarker Discovery in Blood. Methods in Molecular Biology 1619: 433-449, 2018

High-throughput proteomics and protein biomarker discovery in an experimental model of inflammatory hyperalgesia: effects of nimesulide. Drugs 63 Suppl 1: 23-29, 2003

Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics. Journal of the American College of Cardiology 73(17): 2195-2205, 2019

Body fluid proteomics: Prospects for biomarker discovery. Proteomics. Clinical Applications 1(9): 1004-1015, 2007